Dosage Comparison Charts

[2] fewer Rxs for immediate-release oxybutynin for overactive bladder (5/17)
[3] stepping down asthma meds in ADULTS (4/17)
[4] more use of ARBs instead of ACE inhibitors (3/16)
[5] New "intermediate" strength fentanyl patches will raise questions about appropriate dosing (7/15)
[6] Trulicity (TRUE-lih-sih-tee, dulaglutide) is another GLP-1 agonist for type 2 diabetes (12/14)
[7] options to prevent chemo-induced nausea and vomiting (12/14)
[8] more interest in "abuse-deterrent" opioid formulations (5/14)
[9] skyrocketing costs of GENERIC drugs (3/14)
[0] Does it ever make sense to dose extended-release metformin or basal insulin twice daily (11/12)
[-] how to safely switch opioid analgesics (8/12)
-- Strategies for Switching Between Opioid Analgesics
[-] new debate about which anticoagulant is best to prevent strokes in atrial fib patients (3/12)
-- Does Pradaxa (dabigatran) Increase Heart Attack Risk?
[-] more generic ARBs in 2012 (3/12)
-- New Generic ARBs
[-] you'll see more interest in using chlorthalidone instead of hydrochlorothiazide for hypertension (2/12)
-- Hydrochlorothiazide vs Chlorthalidone for Hypertension
[-] more emphasis on preventing bleeding due to anticoagulants in elderly patients (1/12)
-- Oral Anticoagulants: Maximizing Safety
[-] shortages of Adderall (amphetamine salts) and some methylphenidate products (12/11)
-- When and How to Use Stimulants for ADHD
[-] You'll see a big shift in statin use when atorvastatin (Lipitor) goes generic at the end of November (11/11)
-- Shift in Statin Use with Generic Atorvastatin
[-] two new opioid formulations, Oxecta and Lazanda (10/11)
-- New Opioid Formulations: Oxecta and Lazanda